Log in
Biochemistry · Nucleotide Metabolism

Orotic aciduria

Aciduria orotica

Hereditary orotic aciduria is a rare genetic disorder caused by a mutation in the gene encoding the bifunctional enzyme UMP synthase. The condition leads to a block in pyrimidine nucleotide synthesis, massive accumulation of orotic acid, and a severe state known as "pyrimidine starvation".

GeneticsMutation in the gene for the bifunctional enzyme UMP synthase (Type I).
MarkerUrinary excretion of orotate increases 1000-fold (up to 1.5 g/day).
SymptomMegaloblastic anemia unresponsive to folate and vitamin B12 therapy.
TherapyDaily administration of uridine or cytidine (0.5–1 g/day) as a bypass pathway.
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Etiology and biochemical defect

The primary cause of hereditary orotic aciduria is a mutation in the gene encoding the second polyfunctional enzyme of pyrimidine synthesis, UMP synthase. Normally, this bifunctional protein sequentially catalyzes two key reactions converting orotic acid into uridine 5'-monophosphate (UMP):

  1. First, the orotate phosphoribosyltransferase activity functions. Orotic acid interacts with phosphoribosyl pyrophosphate (PRPP), resulting in the formation of orotidine 5'-monophosphate (OMP) and the release of pyrophosphate.
  2. Next, the OMP decarboxylase activity comes into play, cleaving carbon dioxide from OMP to convert it into the final product, UMP.

In a genetic defect of UMP synthase, this pathway is completely blocked. As a result, the conversion of orotate is disrupted, and it accumulates in massive amounts in the blood and tissues. It is important to note that orotic acid itself is not toxic. Nevertheless, its concentration exceeds normal levels to such an extent that urinary excretion reaches 1.5 g/day, which is 1000 times higher than physiological values.

Pathogenesis and clinical presentation

The primary cause of all symptoms in orotic aciduria is "pyrimidine starvation". Since UMP is the precursor for all other pyrimidine nucleotides (UTP, CTP, and TTP), the blockage of its synthesis leaves the body without critical building blocks.

Pyrimidine deficiency leads to the body's inability to maintain the normal rate of nucleic acid synthesis (DNA and RNA). This critically affects tissues with a high turnover rate:

  • Hematopoietic system: The division rate of erythroid progenitor cells drops sharply. Severe megaloblastic anemia develops, which, unlike other forms, is completely unresponsive to standard treatment with vitamin B12 and folic acid preparations.
  • Central nervous system: Marked impairment of intellectual and motor development, along with mental and physical growth retardation, is observed.
  • Internal organs: The function of the gastrointestinal tract and cardiovascular system is compromised.

Thus, the clinical manifestations are caused specifically by the arrest of cell division due to the lack of nucleotides, rather than the toxic action of the accumulating metabolite.

Test your knowledge on this topicTasks from the Biochemistry course bank — instant answer and detailed explanation.

Biochemical basis of treatment

The treatment of orotic aciduria is based on utilizing alternative metabolic pathways (salvage pathways). Patients are prescribed uridine or cytidine supplements at a daily dosage of 0.5–1 g.

The mechanism of action of this replacement therapy addresses two problems simultaneously:

  1. Replenishing the deficit: With the help of the enzyme uridine kinase (or uridine-cytidine kinase), exogenous uridine is phosphorylated by ATP, converting directly into UMP, bypassing the blocked UMP synthase. The resulting UMP is further converted into UTP and CTP. This immediately resolves the "pyrimidine starvation", restores DNA and RNA synthesis, and completely cures megaloblastic anemia.
  2. Eliminating excess orotate: The accumulation of newly formed UTP triggers a feedback inhibition mechanism. Excess UTP allosterically blocks the key regulatory enzyme of de novo pyrimidine synthesis — carbamoyl phosphate synthetase II (CPS II). As a result, precursor synthesis halts, and the pathological production of orotic acid stops.

Briefly: answers to topical questions

Which enzymes are involved in the de novo biosynthesis of orotic acid prior to the UMP synthase step?

The cytosolic CAD enzyme and mitochondrial dihydroorotate dehydrogenase are involved in the de novo biosynthesis of orotic acid prior to the UMP synthase step.

The first three reactions are catalyzed by the polyfunctional CAD enzyme complex, which contains domains with the following activities:

  • Carbamoyl phosphate synthetase II — forms carbamoyl phosphate from glutamine, carbon dioxide, and ATP.
  • Aspartate transcarbamoylase — catalyzes the condensation of carbamoyl phosphate with aspartate to form carbamoylaspartate.
  • Dihydroorotase — provides dehydration and closure of the pyrimidine ring, forming dihydroorotate.

Next, a separate NAD-dependent enzyme acts:

  • Dihydroorotate dehydrogenase — a mitochondrial enzyme that oxidizes dihydroorotate to orotate (orotic acid).
How to memorize

Uridine Corrects UMP deficiency: administer exogenous Uridine, it will quench pyrimidine starvation and pacify orotate synthesis (via CPS II blockade).

Class and exam questions

Why does megaloblastic anemia occur in orotic aciduria?

Due to a shortage of pyrimidines, DNA and RNA synthesis is impaired ("pyrimidine starvation"). This inhibits the division of erythroid cells, leading to the formation of large immature erythrocytes (megaloblasts).

Is orotic acid toxic in high concentrations?

No, orotic acid itself is non-toxic. All clinical manifestations (developmental delay, anemia, heart and GI dysfunction) are exclusively related to pyrimidine nucleotide deficiency.

How does uridine lower urinary orotate levels?

Uridine is converted into UMP and then into UTP. The accumulating UTP inhibits the enzyme carbamoyl phosphate synthetase II (CPS II) via negative feedback, halting the de novo synthesis of orotic acid.

Will vitamin B12 help with anemia in orotic aciduria?

No. Megaloblastic anemia in this disease is specific and does not respond to standard treatment with vitamin B12 or folates, as the root cause lies in the genetic block of pyrimidine synthesis.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "Orotic aciduria" and will explain it in simple terms.

What else to study on this topic

  • Structural organization of the bifunctional UMP synthase enzyme.
  • Allosteric regulation of carbamoyl phosphate synthetase II (CPS II).
  • Salvage pathways of pyrimidine and purine bases.
  • Differential diagnosis of megaloblastic anemias in biochemistry.
  • De novo pyrimidine synthesis: complete sequence of reactions.

Master the entire topic in the "Biochemistry" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Orotic aciduria" and 3,616 more subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 115 video lessons on the subject

Other topics in the "Nucleotide Metabolism" section

Entire "Nucleotide Metabolism" section

Free video lessons: biochemistryShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.